Johnson & Johnson

Latest Headlines

Latest Headlines

Pfizer, J&J, Abbott facing shortages of crucial ingredients in Pakistan

The American Business Council has warned authorities that they had better get the matter sorted out or the country will soon face shortages.

J&J gains EU nod for $21.3B Synthes deal

It took a year after the initial announcement, but Johnson & Johnson ($JNJ) finally gained European regulatory approval for its $21.3 billion bid to buy Synthes.

Top 10 Medical Device R&D Budgets

In the face of a sluggish economy barely recovering from its historic collapse in 2008, almost all of the companies made a concerted effort to boost their R&D spending during their 2011 fiscal years.

J&J plant overhaul turning into 4-year project

William Weldon really is a piece of work. In January he told analysts the consumer products plant in Fort Washington, PA, would open in 2013.

J&J plant fixes behind schedule, hampering brands' return

Johnson & Johnson's manufacturing overhaul has hit some unexpected roadblocks.

J&J and Bristol-Myers ally on another potential hep C blockbuster

The two research powerhouses will conduct a drug-drug interaction study.

J&J pharma revenues tick upward on new products, overseas sales

Johnson & Johnson's first-quarter sales may have taken a hit, but its prescription drugs business actually grew.

Manufacturing issues continue to undermine J&J earnings

Manufacturing issues that have led to recalls and product shortages continue to be a drag on the earnings of Johnson & Johnson, but the company saw its first quarter profits rise by double digits.

Justice, J&J duel over Gorsky's contribution to kickback case

Alex Gorsky's name has surfaced in the U.S. government's Risperdal marketing lawsuit just weeks before he is supposed to step up into the role of CEO at Johnson & Johnson.

Australia, New Zealand, recall J&J hip implant components

Johnson & Johnson is facing more bad news over its metal-on-metal artificial hip implant products, this time in New Zealand and Australia.